Jun Sang
Baoshan, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 21 publications
Prognostic utility of combined 256-detector-row computed tomographic pulmonary angiography and D-dimer in risk stratification of acute pulmonary embolism: a retrospective cohort analysis.
Journal: Frontiers in physiology
Published: January 26, 2026
Ginsenoside Rg1, a Natural Lysosomal Enhancer, Alleviates Parkinson's Disease Pathology via Cathepsin D-Dependent Regulation of α-Synuclein Homeostasis.
Journal: Phytotherapy research : PTR
Published: December 05, 2025
Targeting GRB2 with Polyphyllin H overcomes PIKFYVE inhibitor resistance in bladder cancer by blocking Akt-SREBP1-SCD1 pathway.
Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology
Published: November 15, 2025
Farnesyltransferase inhibitor LB42708 disables oncogenic RAS signaling and overcomes gefitinib resistance in NSCLC via FTase α-subunit and RAS degradation.
Journal: Cell communication and signaling : CCS
Published: October 16, 2025
Paris polyphylla Smith var. yunnanensis-derived saponins potentiate the antitumor activity of GPX4 inhibitors.
Journal: Journal of ethnopharmacology
Published: October 11, 2025
Celastrol synergizes with MEK1 inhibitor nedometinib to overcome resistance in bladder cancer via dual suppression of CDK1/CDC5L and feedback-activated Akt/STAT3.
Journal: Biochemical pharmacology
Published: September 28, 2025
Targeting GRB2-Akt-SREBP1 signaling axis by saponins from Paris polyphylla Smith var. yunnanensis (Franch.) Hand.-Mazz to overcome cisplatin resistance in bladder cancer.
Journal: Journal of ethnopharmacology
Published: May 30, 2025
Anthocyanins and flavonoids derived from Clitoria ternatea L. flower inhibit bladder cancer growth via suppressing fatty acid synthesis mediated by SREBP1 pathway.
Journal: Acta biochimica et biophysica Sinica
Published: October 29, 2024
Jolkinolide B synergistically potentiates the antitumor activity of GPX4 inhibitors via inhibiting TrxR1 in cisplatin-resistant bladder cancer cells.
Journal: Biochemical pharmacology
Published: February 07, 2024
Biscroyunoid A, an Anti-Hepatic Fibrotic 19-nor-Clerodane Diterpenoid Dimer with a C-16-C-12' Linkage from Croton yunnanensis.
Journal: Journal of natural products
Published: February 15, 2023
Discovery of 8,9-seco-ent-Kaurane Diterpenoids as Potential Leads for the Treatment of Triple-Negative Breast Cancer.
Journal: Journal of medicinal chemistry
Published: July 08, 2021
Last Updated: 09/26/2026